How to buy Quotient stock (QTNT)

Quotient is a healthcare equipment & supplies business based in the US. Quotient shares (QTNT) are listed on the NASDAQ and all prices are listed in US Dollars. Quotient employs 450 staff and has a trailing 12-month revenue of around $37.6 million.

Our top picks for where to buy Quotient stock

Buy Quotient stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Quotient stock price (NASDAQ: QTNT)

Use our graph to track the performance of QTNT stocks over time.

Quotient shares at a glance

• Key figures

Information last updated 2023-07-16.

52-week range	$0.00 - $0.00
50-day moving average more info button	$0.66
200-day moving average more info button	$9.22
Wall St. target price	$60.00
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-1.34

Is it a good time to buy Quotient stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Quotient financials

Revenue TTM	$37.6 million
Gross profit TTM	$14.9 million
Return on assets TTM	-40.28%
Return on equity TTM	-737.71%
Profit margin	0%
Book value	$-53.62
Market Capitalization more info button	$1.3 million

TTM: trailing 12 months

Quotient share dividends

We're not expecting Quotient to pay a dividend over the next 12 months.

Have Quotient's shares ever split?

Quotient's shares were split on a 1:40 basis on 2 November 2022 . So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Quotient shares – just the quantity. However, indirectly, the new 3900% higher share price could have impacted the market appetite for Quotient shares which in turn could have impacted Quotient's share price.

Quotient share price volatility

Over the last 12 months, Quotient's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Quotient's is 2.1915. This would suggest that Quotient's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Quotient overview

Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company also offers MosaiQ SDS Microarray that is designed as a serological disease screening microarray comprised assays to detect cytomegalovirus and Syphilis; MosaiQ MDS Microarray that is designed as a molecular disease screening microarray test for donor red cells or source plasma; MosaiQ IH Microarray as a blood grouping microarray; MosaiQ Autoimmune Microarray; MosaiQ COVID-19; and MosaiQ IH3 Microarray. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland. .

Frequently asked questions

What percentage of Quotient is owned by insiders or institutions?
Currently 2.115% of Quotient shares are held by insiders and 45.752% by institutions. How many people work for Quotient?
Latest data suggests 450 work at Quotient. When does the fiscal year end for Quotient?
Quotient's fiscal year ends in March. Where is Quotient based?
Quotient's address is: Business Park Terre Bonne, Eysins, Switzerland, 1262 What is Quotient's ISIN number?
Quotient's international securities identification number is: JE00BLG2ZQ72 What is Quotient's CUSIP number?
Quotient's Committee on Uniform Securities Identification Procedures number is: G73268107